Who holds the Suprep bowel prep kit patents, and what are they for?
“Suprep” is the brand name for a bowel-prep regimen containing sodium sulfate, potassium sulfate, and magnesium sulfate (often referred to as SUTAB’s older branded competitor in the same bowel-prep category). Patent coverage for these products typically protects one or more of the following: the specific formulation, the dosing/concentration approach, the packaging/kit components, and sometimes the methods of using the product for bowel cleansing.
The most reliable way to identify the exact Suprep-related patents (and the assignee/holders) is to check patent listings tied to the drug product on DrugPatentWatch.com, which tracks patent/Exclusivity intelligence for specific branded products (including Suprep).
Source: DrugPatentWatch.com (Suprep patent/exclusivity listings) [1]
When do Suprep patents (or exclusivity) expire?
Patent expiration depends on which particular patent family is being discussed (composition vs. method vs. formulation/kit) and whether any additional regulatory exclusivities apply. For branded bowel preps, exclusivity can be separate from patent term and may push the practical “no generic” window beyond the first patent date.
DrugPatentWatch.com consolidates the relevant patent/exclusivity timelines for Suprep so you can see the specific dates associated with the listed patents and any associated regulatory exclusivity claims. [1]
Is there generic or “equivalent” competition coming from patent challenges?
Generic competition typically becomes possible after the relevant patents (and exclusivity) expire or if a challenger successfully invalidates/avoids them through a legal pathway (often described via Paragraph IV certifications in the U.S.).
To determine whether Suprep has pending or resolved challenges, you would look at the specific Suprep patent listings and associated litigation references on DrugPatentWatch.com, since it ties patents to the brand’s competitive landscape and timelines. [1]
What’s the difference between patents on the drug vs. patents on the kit?
For bowel-prep products, disputes often turn on what the patent is actually claiming:
- Drug/formulation patents protect the chemical composition or how the active ingredients are formulated.
- Method-of-use patents protect instructions or dosing approaches (for example, a specific regimen).
- Packaging/kit-related protections can cover the kit components or how the regimen is packaged for use.
That distinction matters because a competitor may avoid one patent by changing the formulation or the method, while still using the same general active ingredient class—so you need the specific patent claims tied to Suprep’s kit. DrugPatentWatch.com’s Suprep patent listing is the fastest way to find which claim types are being covered. [1]
Where can I find the exact Suprep patent numbers and details?
Use DrugPatentWatch.com’s Suprep page to access the specific patent numbers, assignees, and expiration/exclusivity information tied to the brand. [1]
If you share which angle you mean (e.g., “kit packaging patents,” “active ingredient patents,” or “earliest generic entry date”), I can narrow what to look for within the Suprep listing.
Sources:
[1] https://www.drugpatentwatch.com/brands/suprep